Published online before print December 23, 2004, doi: 10.1161/01.RES.0000154262.07264.12
© 2005 American Heart Association, Inc.
Integrative Physiology |
Collagen Triple Helix Repeat Containing 1, a Novel Secreted Protein in Injured and Diseased Arteries, Inhibits Collagen Expression and Promotes Cell Migration
From the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Correspondence to Volkhard Lindner, MD, PhD, Center for Molecular Medicine Maine Medical Center Research Institute, 81 Research Dr, Scarborough, ME 04074. E-mail lindnv{at}mmc.org
Collagen triple helix repeat containing 1 (Cthrc1) was identified in a screen for differentially expressed sequences in balloon-injured versus normal arteries. Cthrc1 expression was not detectable in normal arteries. However, on injury it was transiently expressed by fibroblasts of the remodeling adventitia and by smooth muscle cells of the neointima. It was also found in the matrix of calcifying human atherosclerotic plaques. CTHRC1 is a secreted 28-kDa protein that is glycosylated and highly conserved from lower chordates to mammals. A short collagen motif with 12 Gly-X-Y repeats appears to be responsible for trimerization of the protein and this renders the molecule susceptible to cleavage by collagenase. Cthrc1 mRNA expression levels are increased in response to transforming growth factor-ß and bone morphogenetic protein-4. Cell migration assays performed with CTHRC1-overexpressing fibroblasts and smooth muscle cells demonstrate that increased CTHRC1 levels are associated with enhanced migratory ability. Furthermore, CTHRC1 overexpression caused a dramatic reduction in collagen type I mRNA and protein levels. Our data indicate that the novel molecule CTHRC1 is transiently expressed in the arterial wall in response to injury where it may contribute to vascular remodeling by limiting collagen matrix deposition and promoting cell migration.
Key Words: calcification • fibrosis • remodeling • adventitia • intima
This article has been cited by other articles:
 |
|
 |
|
  Y. Wang Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy Mol. Cancer Ther., August 1, 2009; 8(8): 2103 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. LeClair, Q. Wang, M. A. Benson, I. Prudovsky, and V. Lindner Intracellular Localization of Cthrc1 Characterizes Differentiated Smooth Muscle Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1332 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-Y. Kang, S. Tsoi, Shan Zhu, Shenghui Su, and H. H. Kay Differential Gene Expression Profiling in HELLP Syndrome Placentas Reproductive Sciences, March 1, 2008; 15(3): 285 - 294. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Maiellaro and W. R. Taylor The role of the adventitia in vascular inflammation Cardiovasc Res, September 1, 2007; 75(4): 640 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gavazzi, C. Deffert, C. Trocme, M. Schappi, F. R. Herrmann, and K.-H. Krause NOX1 Deficiency Protects From Aortic Dissection in Response to Angiotensin II Hypertension, July 1, 2007; 50(1): 189 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. LeClair, T. Durmus, Q. Wang, P. Pyagay, A. Terzic, and V. Lindner Cthrc1 Is a Novel Inhibitor of Transforming Growth Factor-{beta} Signaling and Neointimal Lesion Formation Circ. Res., March 30, 2007; 100(6): 826 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tang, D. L. Dai, M. Su, M. Martinka, G. Li, and Y. Zhou Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers. Clin. Cancer Res., June 15, 2006; 12(12): 3716 - 3722. [Abstract] [Full Text] [PDF]
|
|